NeuBase Therapeutics Inc Forecast, price target & analysts
$0.38
0.00%
Nasdaq,
Fri, Sep 06 2024
NeuBase Therapeutics Inc Target price 2024 - Analyst rating & recommendation
Powered by
NeuBase Therapeutics Inc Classifications & Recommendation:
Buy
33%
Hold
67%
NeuBase Therapeutics Inc Price Target
| Target Price | $200.00 |
| Price | $0.38 |
| Potential |
52,810.10%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a NeuBase Therapeutics Inc price target 2025.
The average NeuBase Therapeutics Inc target price is $200.00.
This is
52,810.10%
register free of charge
|
|
| A rating was issued by 3 analysts: 1 Analysts recommend NeuBase Therapeutics Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the NeuBase Therapeutics Inc stock has an average upside potential 2025 of
52,810.10%
register free of charge
|
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
